FDA Import Refusal 1FX-9003947-9/20002/1 — ASTRAZENECA PHARMA
The FDA refused shipment 1FX-9003947-9/20002/1 from ASTRAZENECA PHARMA (India) on July 2, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- July 2, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75